Date：27 July (Thursday)
Time：14:00 – 15:30 (GMT+8)
CEO & Venture Partner
LUCA Science Inc., Axil Capital Partners LLP
Dr. Rick C. Tsai is the Chief Executive Officer of LUCA Science and Venture Partner for Axil Capital Partners in Tokyo, Japan. Before joining LUCA Science, he served as Executive Officer and head of Medical Affairs department for MSD K.K., a subsidiary of Merck & Co. Inc. During his tenure at MSD, he has also led the Regulatory Affairs and Clinical Development team in multiple therapeutic areas in Japan. In addition to MSD, Rick has worked as a Medical Director for Allergan in Japan China, Taiwan and Hong Kong. Prior to joining pharmaceutical industry Rick was an Oral & Maxillofacial surgeon and research scientist at New York Presbyterian Hospital and Columbia University.
Rick holds a DMD (Doctor of Dental Medicine) degree from Harvard University and MD (Doctor of Medicine) from Columbia University.